Comparison of the effects of EECP Combined with Cardiac Rehabilitation and only Cardiac Rehabilitation on the treatment of ischemic heart disease
Not Applicable
- Conditions
- Ischemic heart disease.Ischemic heart diseaseI20-I25
- Registration Number
- IRCT201111024422N3
- Lead Sponsor
- vice-chancellor for Research, Tabriz University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
patients after myocardial infarction, age over 30 years old, ischemic heart disease which is documented by at least one of the followings: angiography, Perfusion scan, ECG, exercise Test, EF=30
Exclusion criteria: Arrhythmias that will lead to impaired performance, susceptibility to bleeding, Active thrombophlebitis, proven aortic aneurysms that require to surgery, pregnancy, patients with significant valvular heart disease (Severe AI-severe AS - severe MS), using of nitrocantine
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method evel of blood hsCRP. Timepoint: before beginning and at the end of study for all patients,also for group B befor EECP. Method of measurement: using the kit of hsCRP(mg/lit).;Level of blood Nitric oxide. Timepoint: before beginning and at the end of study for all patients,also for group B befor EECP. Method of measurement: using the kit of Nitric oxide (umol/lit).;Level of blood Endotelin-1. Timepoint: before beginning and at the end of study for all patients ,also for group B before EECP. Method of measurement: using the kit of Endotelin-1( pg/lit).
- Secondary Outcome Measures
Name Time Method Clinical parameters. Timepoint: before beginning and at the end of study for all patients. Method of measurement: quality of life questionnaire sf36, Canadian Cardiovascular Society Angina scale.